Skip to content

LivaNova LIVN Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

Haemonetics logo
HaemoneticsHAE
-$86.61M
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%
Baxter International logo
Baxter InternationalBAX
-$133M-104%
Medtronic logo
MedtronicMDT
ResMed logo
ResMedRMD
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's cash provided by (used in) investing activity, including discontinued operation?
LivaNova (LIVN) reported cash provided by (used in) investing activity, including discontinued operation of -$14.58M in Q1 2026.
How has LivaNova's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
LivaNova's cash provided by (used in) investing activity, including discontinued operation decreased by 37.2% year-over-year, from -$10.63M to -$14.58M.
What is the long-term trend for LivaNova's cash provided by (used in) investing activity, including discontinued operation?
Over 3 years (2022 to 2025), LivaNova's cash provided by (used in) investing activity, including discontinued operation has grown at a 23.8% compound annual growth rate (CAGR), from -$38.41M to -$72.91M.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.